Literature DB >> 1531650

Identification of a high molecular weight macrophage colony-stimulating factor as a glycosaminoglycan-containing species.

S Suzu1, T Ohtsuki, N Yanai, Z Takatsu, T Kawashima, F Takaku, N Nagata, K Motoyoshi.   

Abstract

Chinese hamster ovary cells transfected with a 4.0-kilobase macrophage colony-stimulating factor (M-CSF) cDNA express two different M-CSF species; one has an apparent molecular weight of 85,000 and is identified as a homodimer of a 43-kDa subunit, and the other has an indeterminate structure greater than 200 kDa. In this study, we investigated the structure of the high molecular weight M-CSF by immunochemical procedures. The high molecular weight M-CSF was easily purified, since it bound tightly to DEAE-Sephacel and eluted at a characteristically high salt concentration. The high molecular weight M-CSF migrated as a diffuse band of over than 200,000 on nonreducing sodium dodecyl sulfate-polyacrylamide gels. Analysis of the same samples under reducing conditions revealed that the larger species consisted of a heteromer of the 43- and 150-200-kDa M-CSF subunits. Digestion of the 150-200-kDa M-CSF subunit with chondroitinase, which degrades the chondroitin sulfate glycosaminoglycan chain, yielded a 100 kDa band. This species was secreted instead of 150-200-kDa species when the cells were cultured in the presence of beta-D-xyloside, which inhibits the elongation of the chondroitin sulfate glycosaminoglycan chain in proteoglycans, providing additional evidence for the existence of a chondroitin sulfate chain in the 150-200-kDa M-CSF subunit. Removal of O- and N-linked carbohydrate from the 150-200-kDa subunit yielded a polypeptide chain with a larger molecular mass (approximately 45 kDa) than that of the 43-kDa subunit (approximately 25 kDa). Collectively, these results indicate that the 150-200-kDa M-CSF subunit is a proteoglycan with a core protein that may be an alternatively processed form of M-CSF.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531650

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice.

Authors:  J H Qiao; J Tripathi; N K Mishra; Y Cai; S Tripathi; X P Wang; S Imes; M C Fishbein; S K Clinton; P Libby; A J Lusis; T B Rajavashisth
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Developmental and functional significance of the CSF-1 proteoglycan chondroitin sulfate chain.

Authors:  Sayan Nandi; Mohammed P Akhter; Mark F Seifert; Xu-Ming Dai; E Richard Stanley
Journal:  Blood       Date:  2005-10-06       Impact factor: 22.113

Review 3.  Cytokines and proteoglycans.

Authors:  J J Nietfeld
Journal:  Experientia       Date:  1993-05-15

Review 4.  Small proteoglycans.

Authors:  H Kresse; H Hausser; E Schönherr
Journal:  Experientia       Date:  1993-05-15

5.  Proteoglycan form of macrophage colony-stimulating factor binds low density lipoprotein.

Authors:  S Suzu; T Inaba; N Yanai; T Kawashima; N Yamada; T Oka; R Machinami; T Ohtsuki; F Kimura; S Kondo
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

Review 6.  Regulation of Embryonic and Postnatal Development by the CSF-1 Receptor.

Authors:  Violeta Chitu; E Richard Stanley
Journal:  Curr Top Dev Biol       Date:  2016-12-01       Impact factor: 4.897

7.  Immunological and biochemical characterization of biglycan-like haemopoietic factor.

Authors:  A Kikuchi; N Iwakami; K Takahashi; J Suzuki; J Kondo; E Yamada; I Nonaka; I Kamo
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

8.  Immunohistochemical identification of proteoglycan form of macrophage colony-stimulating factor on bone surface.

Authors:  T Ohtsuki; K Hatake; S Suzu; K Saito; K Motoyoshi; Y Miura
Journal:  Calcif Tissue Int       Date:  1995-09       Impact factor: 4.333

Review 9.  CSF-1 receptor signaling in myeloid cells.

Authors:  E Richard Stanley; Violeta Chitu
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-06-02       Impact factor: 10.005

10.  Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice.

Authors:  T Rajavashisth; J H Qiao; S Tripathi; J Tripathi; N Mishra; M Hua; X P Wang; A Loussararian; S Clinton; P Libby; A Lusis
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.